Join BioQC Insights

Related events as part of the webinar series

Register now:

Webinar

Advanced ELISA-MS™ for Host Cell Protein (HCP) coverage and ELISA Antibody Characterisation

Your registration was successful, and you’ll get an email with instructions on how to watch and attend the presentation.

If you know a colleague who would benefit from this presentation, use the form to invite them.

We recommend adding the event to your calendar using the button below. This includes the auditorium link, which can also be accessed before the event to submit questions for our presenters.

Add to Calendar

Presenters / Panellists

Presenters / Panellists
Anette Draborg, PhDSubject-matter expert in ELISA characterisationAlphalyse (Denmark)Anette Draborg, PhD, is a subject-matter expert in ELISA characterisation at Alphalyse, where she applies her extensive research experience in immunology and immunochemical assay development to support biopharmaceutical clients. She specialises in ELISA-MS™ coverage assessment, which combines immunocapture with liquid chromatography-mass spectrometry (LC-MS) to assess the suitability of ELISAs for Host Cell Protein (HCP) detection and control. Since joining Alphalyse in 2021, Anette has helped numerous clients evaluate the performance of their HCP-ELISAs using ELISA-MS™, ensuring fit-for-purpose assays that meet regulatory expectations and support the development of safe biologics.
Ejvind Mørtz, PhDCo-Founder & COOAlphalyse (Denmark)Ejvind holds a PhD from the University of Southern Denmark in Protein Chemistry & Molecular Biology. He has more than 20 years of experience developing protein analyses and mass spectrometry methods in the research & development of protein biologics, vaccines, monoclonal antibodies, therapeutic proteins, and cell and gene therapies.

Moderators

Moderators
Prof. Dr. Cari Sänger-van de GriendScientific DirectorBioQCExpert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing.
Dr. Ewoud van TrichtScientific DirectorBioQCExpert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.

In Collaboration with:

Ask a Question

Join the conversation (or start a discussion) on the BioQC User Community.

 

Contact Us

If you have any questions about the event, don’t hesitate to get in touch with the BioQC Team: Feedback & General Enquiry